ExploreWatchlistsPricing
  1. JP-listed companies
  2. VITAL KSK HOLDINGS,INC.
  3. Financials
  4. Total cash & short-term investments

VITAL KSK HOLDINGS,INC. (3151)

Market cap
¥78.1B
P/E ratio
9.8x
Vital KSK Holdings distributes pharmaceuticals to hospitals, pharmacies and veterinary practices while operating community pharmacies and healthcare services across Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 202523,099-33.46%
Mar 31, 202434,712+82.42%
Mar 31, 202319,029-29.45%
Mar 31, 202226,971-9.44%
Mar 31, 202129,784-9.95%
Mar 31, 202033,074-23.52%
Mar 31, 201943,248+52.89%
Mar 31, 201828,287+22.87%
Mar 31, 201723,022-13.91%
Mar 31, 201626,741-24.39%
Mar 31, 201535,368

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat